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A human factors evaluation was conducted to inform hospital procurement decision-making in selecting a general-purpose infu-
sion pump to be used hospital-wide. Three infusion pumps from diﬀerent vendors were involved in the evaluation, which consisted
of two phases: a human factors heuristic assessment of the pumps according to several criteria, and user testing in ﬁve clinical areas.
The clinical areas were: Oncology, Medical/Surgical, Pediatric, ICU, and Anaesthesiology. Fourteen nurses and three anaesthetists
participated in the user testing. Reasonable agreement was observed between results of both phases of the evaluation, and overall
results clearly favoured one of the infusion pumps over the others. It is recommended that a human factors evaluation should be
performed to inﬂuence all hospital procurement decisions when purchasing medical devices, to ensure the best devices are selected
for the end users and to ultimately enhance patient safety.
 2004 Elsevier Inc. All rights reserved.
Keywords: Infusion pump; Human factors; Hospital procurement; User testing; Medical error; Patient safety; Equipment evaluation1. Introduction
According to the recent Canadian Adverse Events
Study [1], 7.5% of patients admitted to acute care hospi-
tals in Canada experienced at least one adverse event
during the year 2000, with drug- or ﬂuid-related events
being the most common type of adverse events, next
to those related to surgical procedures. The study also
found that 36.9% of those patients had adverse events
that could have been prevented, and that between
9250 and 23,750 deaths from adverse events could have
been prevented in the year 2000. Human factors engi-
neering (HFE) is frequently being cited as an important
method to reduce medical error and adverse events and
to increase patient safety, when it is applied to the design
and evaluation of medical devices, including infusion1532-0464/$ - see front matter  2004 Elsevier Inc. All rights reserved.
doi:10.1016/j.jbi.2004.11.008
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E-mail address: gginsburg@thc.on.ca.pumps [2–10]. HFE is starting to be used to inﬂuence
medical device procurement decisions in hospitals, to en-
sure that the safest and most eﬃcient and eﬀective de-
vices are purchased. The University Health Network
in Toronto, Ontario used HFE to evaluate electrosurgi-
cal units on the market [7]. This process inﬂuenced the
purchasing decision, and in the end the chosen product
was the oldest on the market and had the fewest new
features, but it was deemed to be the most usable and
had the highest acceptance by clinical users. HFE was
also used by the Veterans Health Administration to
compare the usability of various infusion pumps in or-
der to inform procurement decisions [11]. Recently, Kes-
elman et al. [12] analysed the decision-making process
for infusion pump selection in a large hospital, and they
emphasized the need to incorporate HFE into procure-
ment decisions. Health Canada recently issued a notice
on infusion pumps to hospitals, recommending that be-
fore selecting a pump, the hospital should determine
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[13], to reduce the major safety concerns associated with
infusion pumps. The notice indicates that between 1987
and 2003, 291 incidents associated with general-purpose
infusion pumps were reported in Canada. This number
is likely lower than the actual number of incidents due
to under-reporting.2. Background
Trillium Health Centre is one of Canadas leading
community hospitals, serving over one million residents
of Mississauga, south Etobicoke, and surrounding areas
across two sites. In March 2004, Trilliums existing con-
tract with a general-purpose infusion pump vendor was
to expire. Several months prior to this date, it was iden-
tiﬁed that a new contract would be sought for general-
purpose infusion pumps that incorporated safety fea-
tures and utilized the latest ‘‘smart pump technology,’’
such as dose error reduction systems and automated
programming. In addition, it was deemed important,
both from a patient safety and cost eﬀectiveness perspec-
tive, that pump usage be standardized across the organi-
zation so that one vendors product be used in all clinical
areas. This would ensure that intravenous sets and
pumps would not have to be switched when patients
are transferred to and from certain units. To this end,
a Request For Proposal (RFP) was issued to replace
over 500 general-purpose infusion pumps in the hospi-
tal, and three vendors were subsequently identiﬁed as
meeting the RFP requirements (hereon in referred to
as Vendors A, B, and C). Interestingly, Trilliums cur-
rent contract is with a prior model of Vendor Cs infu-
sion pump (approximately 450 such pumps are used in
the hospital) and a prior model of Vendor Bs infusion
pump (approximately 70 such pumps are used in the
hospital). All three pumps consisted of human–comput-
er interfaces, requiring human interaction. All pumps
had drug libraries and dose-error reduction systems.
Following the identiﬁcation of the three vendors,
each vendor was requested to demonstrate their pump
technology, including dose-error reduction systems and
automated programming if available, according to
numerous clinical simulations that were developed by
Pharmacy and various Clinical Leaders throughout the
hospital. Staﬀ and Management were invited to the
demonstrations, following which they rated the usability
of various features of the systems that were demon-
strated. Two such demonstration sessions were given
per vendor, one of which included basic, unsupervised
and unstructured hands-on trial by members of the
audience. While user participation in hospital medical
device selection decision-making is both important and
encouraged, there was no strong preference that came
out of the demonstration and usability rating process.Each user did not have enough hands-on experience
with the features to be able to accurately judge their
usability, and the clinical simulations were not necessar-
ily applicable to every user and did not cover each users
most common and problematic tasks. Also, a structured
observation of the users hands-on interaction with the
pumps was not conducted, which could have revealed
valuable information on the errors that were made and
what users found frustrating.
As such, another phase of the selection process was
instated, wherein a thorough human factors evaluation
of the three infusion pumps was conducted by a Human
Factors Engineer, so that the best infusion pump system
for the end user could be recommended, and in so-doing
patient safety could be enhanced. Although many hospi-
tals face competing ﬁnancial constraints, pressures from
diﬀerent stakeholder groups, various organizational
considerations, and other factors during their decision-
making processes [12], the outcome of the human fac-
tors evaluation formed the basis for the ﬁnal decision
of which system to purchase, as Trillium Health Centre
is committed ﬁrst and foremost to patient safety and pa-
tient-centred care. The purpose of this paper is to share
methods used in the human factors evaluation and to
illustrate how these methods led to results which clearly
showed which system would have the largest impact on
improving patient safety. Human factors medical device
evaluations, using similar methods to the ones described
in this paper, should form the basis of all hospital pro-
curement decisions, to mitigate risk, reduce medical er-
ror, and enhance patient safety.3. Methods
Two phases of the human factors evaluation of the
infusion pumps were conducted. The ﬁrst phase in-
volved a heuristic evaluation of each pump according
to four sets of criteria. Fifteen human factors principles
formed the basis of the ﬁrst set of criteria. These princi-
ples were adapted from a set of human factors principles
developed by Nielson [14], a set of rules developed by
Schneiderman [15], as well as from speciﬁc consider-
ations in this study, such as alarm audibility. The 15 hu-
man factors principles were:
 Visibility of system status,
 Match between system and world,
 User control and freedom,
 Consistency and standards,
 Error prevention,
 Recognition rather than recall,
 Flexibility and ease-of-use,
 Aesthetic and minimalist design,
 Help users diagnose and recover from errors,
 Help and documentation,
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 Anticipate user action,
 Color blindness,
 Readability,
 Audibility.
The second set of criteria included standards, related
to human factors, established by regulatory bodies, such
as the Food Drug Administration (FDA) [2,3], Institute
for Safe Medication Practices (ISMP) [16], Health Can-
ada [13], and ECRI [17] for medical devices in general or
speciﬁcally for infusion pumps. These standards in-
cluded the usability and content of the drug libraries,
the information that is displayed by the devices, and
the ability of users to override various limits and
warnings.
The third set of criteria was adapted from a usability
rating form developed in the initial phases of the infu-
sion pump selection process, and contained characteris-
tics such as:
 Set easy to prime and load,
 Easy to titrate ﬂow rates,
 Key information visible on one screen,
 Visual indicators to show pump is infusing,
 Easy to view battery level,
 Easy to view pressure level,
 Pump lightweight and easy to transport.
The fourth and ﬁnal set of criteria was developed
from the RFP requirements that were sent out to all
the vendors before the selection process was com-
menced, and included requirements such as:
 Pump has large graphics to indicate ﬂowrate and
volume,
 Pump keypad has tactile feedback,
 Pump has an audible indication when a key has been
activated successfully,
 Pump has a visible channel indicator for alarm condi-
tions, and
 Pump occlusion threshold is easily user adjustable in
mmHg.
The Human Factors Engineer rated each infusion
pump according to each criterion in the four sets of cri-
teria on a scale of one to ﬁve, with one being unaccept-
able from a usability perspective, and ﬁve being
excellent. These were overall ratings based on the usabil-
ity violations that were found to each criterion and the
severities of those violations. The scores within each
set of criteria were then added up for each pump, as well
as the total score of each set of criteria to give each
pump an overall usability score. In addition, to the
usability ratings, the Human Factors Engineer also per-
formed a task analysis [3,18] for several common tasksthat a user would perform with an infusion pump. These
included:
 Turning on and oﬀ the pump,
 Loading and unloading a set,
 Programming a basic infusion,
 Programming a drug infusion from scratch,
 Programming a drug infusion from a drug library,
and
 Programming an infusion on a secondary line.
The task analysis consisted of an assessment of the
users action to perform each step of the task, the infor-
mation provided by the device, the information not pro-
vided by the device, the device response, the observed
problems and the severity of those problems (low, med-
ium, or high from a patient safety perspective). Together,
the information gained from the usability ratings and the
task analyses not only served to illustrate the usability
strengths and weaknesses of the pumps, but also helped
to shed light on why users made certain errors during
the user testing phase of the human factors evaluation.
The second phase of the human factors evaluation
consisted of user testing in which the Human Factors
Engineer visited diﬀerent clinical areas with the pumps
and observed users as they performed realistic clinical
scenarios with each infusion pump. In total, ﬁve clinical
areas participated in the user testing, and there were 17
participants in total: four nurses from Oncology, four
nurses from Medical/Surgical, three nurses from Pediat-
rics, three nurses from Intensive Care (ICU), and three
anaesthetists from Anaesthesiology. All 17 participants
had prior experience in programming a previous but
very similar version of Vendor Cs product, and all clin-
ical areas except for Anaesthesiology currently use Ven-
dor Cs previous product. The only diﬀerence between
the previous version of Vendor Cs product and the ver-
sion under consideration, in terms of programming, is
the addition of barcode scanning capability. Further-
more, one participant from the ICU and all anaesthetist
participants had prior experience in programming a pre-
vious, but very similar, version of Vendor Bs infusion
pump. There is no signiﬁcant diﬀerence between pro-
gramming the prior version of Vendor Bs product and
the current version under consideration. None of the
participants had any previous training or experience in
programming Vendor As pump.
The clinical scenarios were developed by each clinical
leader speciﬁcally for his/her own area, based on the
most common tasks that users in that area perform with
infusion pumps. These tasks included a combination of
programming basic infusions, piggyback infusions, and
drug infusions, as well as other tasks. Each user partic-
ipated in three sessions, one for each pump. The same
scenarios were used for each pump, and the order of
the pumps across the clinical units was counterbalanced.
Table 1
Usability scores for the four sets of criteria
Set of criteria Vendor A Vendor B Vendor C
Human factors
principles (15a, 75b)
56 57 47
ECRI, FDA, ISMP,
and Health Canada
standards (11, 55)
48 48 38
Usability rating form (18, 90) 80 78 70
RFP requirements (17, 85) 76 69 73
Total usability score (61, 305) 260 252 228
a The number of criteria in the set.
b The maximum possible score if the pump received a ﬁve on each
criterion in the set.
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day and a half, with either their ﬁrst session in the after-
noon of one day and their second and third sessions in
the morning and afternoon of the next day respectively,
or their ﬁrst two sessions in the morning and afternoon
of one day and their third session in the morning of the
next day. Each session took approximately 40 min. The
anaesthetists completed all three sessions consecutively,
within approximately 90 min, due to scheduling diﬃcul-
ties. At the beginning of each session, participants re-
ceived approximately 10 min of basic training on the
pump to be programmed in that session. At the end of
each session, participants completed a form to rate the
usability of a set of characteristics related to the tasks
they had performed, and at the end of the third session
participants ﬁlled out a comparison form to indicate
which pump they preferred based on each characteristic,
as well as overall.
Due to scheduling challenges as well as the nature of
work that the participants had to put on hold while par-
ticipating in the sessions, it was not possible to strictly
control the test environment. The Oncology sessions
were conducted in a quiet patient lounge, although the
paging system was still audible and the participants were
occasionally interrupted by nurses who were covering
for them. In the Medical/Surgical and Pediatric areas,
the sessions were conducted in the nursing lounges,
which occasionally saw some traﬃc by other nurses.
The ICU testing conditions were the most representative
of actual conditions, as the participants performed the
scenarios either inside or right outside of the patient
rooms, always keeping an eye on their patient and some-
times having to go and attend to them during a scenario.
In Anaesthesiology, the sessions were conducted in the
Anaesthesia Oﬃce, in which other Anaesthetists were
usually on break or in conversation, or monitoring their
patients in the operating room via remote patient
monitors.
While the participants performed the scenarios, the
Human Factors Engineer observed and recorded in
writing the usability errors that were committed. A
usability error was deﬁned as any action deviating from
the correct or most accurate or eﬃcient programming
sequence. In the data analysis, usability errors were fur-
ther broken up into critical and non-critical errors. A
critical error was deﬁned as an error that could have
led to a negative consequence for a patient (such as
selecting the wrong concentration of a drug from the
drug library), whereas a non-critical error was deﬁned
as an error that would not have led to a negative conse-
quence for a patient (such as trying to enter a value be-
fore selecting the parameter). Critical errors were also
further divided into detected and undetected errors. A
detected error could have resulted from an infusion
pump alerting the user to the error via a visual alert or
audible alarm, or by the user simply realizing the mis-take on his/her own. Thus, the worst possible usability
error a user could make would be an undetected, critical
error. The total number of usability errors, critical
usability errors, and critical undetected usability errors
were tallied up for each pump within each clinical area,
as well as across all clinical areas.4. Results and discussion
Table 1 summarizes the results of the human factors
heuristic phase of the study. There were various usabil-
ity issues associated with each infusion pump. Vendors
A and B seemed to have comparable total scores, with
Vendor A slightly higher and Vendor C lagging behind.
Table 2 illustrates examples of the usability strengths
and weaknesses that were found with each pump. The
heuristic assessment revealed that certain strengths of
one pump were weaknesses of another, and vice versa.
At ﬁrst glance, some of the weaknesses illustrated in Ta-
ble 2 may actually seem like strengths, but it depends on
the perspective from which one views them, because
sometimes there is a trade-oﬀ between safety and eﬃ-
ciency. For example, although having the new loca-
tion/new patient screen automatically disappear in
Vendor Bs product is more eﬃcient in that a user does
not have to make a selection at all if they are program-
ming for the same patient in the same location, it is easy
to miss this screen altogether if one is occupied with
something else after turning on the pump (such as prim-
ing the set) or if one gets interrupted [8], and hence the
wrong drugs and dosing limits could be loaded into the
drug library.
Fig. 1 illustrates the total number of usability errors
committed by users in each clinical area for each infu-
sion pump, and shows that substantially fewer errors
were made in the Oncology, Medical/Surgical, and Pedi-
atric areas with Vendor As infusion pump compared to
the other two vendors pumps. In all three of these units,
nurses program a previous but very similar version of
Vendor Cs infusion pump multiple times per shift,
and had no previous experience in programming Vendor
Table 2
Examples of usability strengths and weaknesses associated with each infusion pump
Strengths Weaknesses
Vendor A  Easy to search drug library  Two separate screens for programming a drug infusion
 Pre-programmed concentrations are displayed in drug library  Confusing to turn oﬀ channel/pumps
 Structured, forced programming  Diﬃcult to view scrolling channel display
Vendor B  Programmed dose is shown in dosing limits warning  Pre-programmed concentrations are not displayed in drug library
 All drug infusion programming done on one screen  Programming modes are not all visible/available
 All options displayed on one screen  New location/new patient screen automatically disappears
Vendor C  Easy to program basic rate-volume  No prompt to press RUN
 Both primary and piggyback channels displayed  Location for programming certain parameters is confusing
 Drug name displayed in large letters  Diﬃcult to navigate menus/modes
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come poor device design. Similar numbers of usability
errors were made with the pumps in ICU and in
Anaesthesiology.
As shown in Fig. 2, a similar trend was observed for
the total number of critical usability errors committed
by participants in the Oncology, Medical/Surgical, and
Pediatric areas, and as well, slightly fewer critical errors
were made in ICU and Anaesthesiology with Vendor
As product versus the other two infusion pumps.
The number of undetected critical errors made in
each clinical area is shown in Fig. 3, and again a similarFig. 2. Total number of critical usability errors committed in each
clinical area.
Fig. 1. Total number of usability errors made in each clinical area.trend is observed. Fig. 4 illustrates the total number of
usability, critical, and undetected critical errors commit-
ted for each infusion pump across all clinical areas.
Overall, performance was better in all error categories
with Vendor As device than with the other vendors
infusion pumps.
Table 3 shows overall user preferences across all clin-
ical areas for various infusion pump tasks or character-
istics. It is interesting that these preferences do not
always reﬂect user performance. In this study, this phe-
nomenon may be attributed to a few factors: (a) all users
were already familiar with Vendor Cs infusion pump,ig. 3. Total number of undetected critical errors committed in eachFFig. 4. Total number of errors across clinical areas.
clinical area.
Table 3
User preferences across all clinical areas
Task or characteristic Number of users who chose each
Vendors product
Vendor A Vendor B Vendor C
Easiest to program
a basic infusion
4 5 12
Easiest to program
from a drug library
8 3 5
Easiest to program from
a drug calculator
10 5 4
Easiest to load a set into 8 5 7
Easiest to transport 12 2 6
Most user-friendly prompts 6 5 5
Most user-friendly keypad 5 6 9
Most user-friendly display 6 6 9
Overall preference 8 5 8
Note. A few participants rated some pumps equal in a few categories,
so the numbers sometimes add up to more than the total number of
participants in the study.
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pump, (b) there are usability strengths and weaknesses
associated with each device, and (c) the tasks or charac-
teristics for which users were stating their device prefer-
ences were related to ease-of-use rather than safety. This
clearly illustrates the need to perform user testing in
which errors are observed and analyzed.5. Conclusions
There was general agreement between results of
both phases of the human factors evaluation. Overall,
results favoured Vendor As infusion pump over Ven-
dor B or Vendor Cs infusion pumps. This study also
illustrates the value of conducting both phases in a hu-
man factors evaluation of medical devices, a heuristic
assessment phase and a user testing phase, as both
phases complement each other and reveal important
information. The heuristic assessment phase reveals
information on aspects of the design that could poten-
tially be problematic for users and lead to errors or
frustrations, but the likelihood and magnitude of those
errors can only be seen through user testing. Further-
more, user testing takes into account the speciﬁc skills
and competencies of users in an organization, espe-
cially when conducted with members from all user
groups. The errors made by users during the user test-
ing phase can be better understood by the detailed
information gained in the heuristic evaluation phase,
and that information can then be incorporated in a
proactive manner into user training programs on the
selected product. Data obtained from the heuristic
evaluation phase can also be used to guide design
changes and modiﬁcations of the devices to improve
their usability and safety.6. Recommendations
It is recommended that the human factors evaluation
that was conducted in this study be applied in future
medical device procurement decisions conducted at Tril-
lium Health Centre, to ensure that the best products for
the end user are selected and to enhance patient safety.
Other health care facilities are also encouraged to use
this process. Furthermore, it is also recommended that
the results of this study for each vendor be made avail-
able to that speciﬁc vendor, in an eﬀort to inﬂuence fu-
ture product design. Finally, all three pumps had human
factors usability issues that caused certain errors to be
committed. When user training is conducted throughout
the hospital on the selected pump, the training program
should be tailored to address these problems so that
users become aware of them up front and are better pre-
pared to deal with them.7. Limitations
There were several limitations to this study, most re-
volving around time and resource constraints, however
it is unlikely that the strong trends observed in the re-
sults between Vendor A and Vendors B and C would
change if these limitations were to be addressed in fu-
ture studies. First of all, no novice users (users who
had no previous experience in programming infusion
pumps) participated in the user testing, as no such nov-
ices were available to participate in the study. Also,
there was a small sample size of participants tested in
each clinical area, and the clinical scenarios did not in-
clude all tasks that users perform with the pumps, but
was rather a representation of the most common tasks
and focused mainly on pump programming. Pump or-
der was not counterbalanced across participants within
each area, and testing conditions were not strictly con-
trolled across participants or clinical areas. Finally, ob-
served errors were recorded by hand, but more accurate
observation equipment, such as video recording, or an
analysis of the key press logs on the pumps, may have
revealed errors that could have been missed by the
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